25 Aug, 2026
25 Aug, 2026
This article is medically reviewed by Dr. Saket Mittal, Consultant - Surgical Oncology.
A breast lump or an abnormal finding on a screening mammogram is often what leads to further evaluation for possible breast cancer. In many cases, the finding is non-cancerous. However, when a breast abnormality persists or imaging shows suspicious changes, additional testing becomes necessary. One challenge with early breast cancer symptoms is that they are not always painful or clearly noticeable, which can delay diagnosis in some patients.
Breast cancer screening and diagnosis now involve multiple steps rather than a single test. Depending on the clinical findings, evaluation may include a clinical breast examination, mammography, ultrasound imaging, MRI scans, and, when necessary, a breast biopsy. Research published in the Journal of Clinical Oncology has shown that evidence-based screening programs can reduce late-stage breast cancer diagnoses and improve early detection.
In India, breast cancer is currently the most commonly diagnosed cancer among women, and awareness of early symptoms remains limited in many regions. The diagnostic process may differ from one patient to another, but understanding the different stages of evaluation can make the process easier to follow.
Breast cancer diagnosis often begins with imaging tests. A breast oncologist or radiologist reviews your mammogram, examines any physical changes, and decides what comes next. Most women undergo a screening mammogram first. And only a small percentage end up needing further testing. Most of the time, everything looks just fine.
A mammogram for breast cancer is the standard starting point. It uses X-rays to examine breast tissue to detect masses, calcifications, and structural changes before you feel anything. For women with dense breast tissue, a breast ultrasound follows because dense tissue hides abnormalities on a standard mammogram.
However, a mammogram alone cannot confirm cancer. Its role is to identify suspicious areas that need further evaluation.
An abnormal result does not always mean cancer. It means something needs a second look. The radiologist assigns a BI-RADS score (Breast Imaging Reporting and Data System), ranging from 0 to 6. A score of 1 or 2 is normal. A score of 4 or 5 warrants a biopsy. Mammography detects most cancers in average-risk women, but it's less sensitive in dense breast tissue, which is where breast MRI and contrast-enhanced mammography come in.
Here's how breast cancer imaging tests compare:
| Test | Best For | Limitation |
|---|---|---|
| Mammogram | Routine screening, calcifications | Less effective in dense tissue |
| Breast ultrasound | Evaluating palpable lumps, dense tissue | Can't detect microcalcifications |
| Breast MRI | High-risk women, dense tissue, staging | Expensive, higher chance of false alarms |
| Contrast-Enhanced Mammography | Dense tissue, post-treatment monitoring | Less widely available |
Mammography remains the primary screening tool for breast cancer. How accurate is mammography? It is highly effective for routine screening, although its accuracy may be lower in women with dense breast tissue.
It can, but it is not used as a standalone screening tool a breast ultrasound helps determine is whether a mass is solid or fluid-filled. Solid masses rise. more concern.
It provides additional detail that mammography alone may not detect; actually, it's most useful when mammography has already flagged something suspicious. In some cases, additional imaging may be needed. Is an MRI necessary for breast cancer diagnosis? Not always. Breast MRI is generally recommended for high-risk women with dense breast tissue or when mammogram and ultrasound findings require further evaluation.
When imaging shows a suspicious area, a breast biopsy is used to determine whether cancer cells are present. The most common method is a core needle biopsy, in which a hollow needle is used to collect tissue samples for histopathological examination under a microscope. A sentinel lymph node biopsy may also be performed to determine whether the cancer has spread beyond the breast tissue.
Stages involved in breast cancer diagnosis range from Stage 0 (non-invasive disease) to Stage IV (cancer that has spread to distant organs).
Cancer isn't what most breast lumps are. Cysts are fluid-filled sacs that often appear and disappear with hormonal changes. Cancerous masses are typically solid, irregularly shaped, and don't resolve on their own.
Breast cancer staging happens after a biopsy confirms malignancy, and it determines how far the disease has spread. The stages range from early-stage breast cancer (confined to the breast) to metastatic breast cancer (spread to distant organs). Tumor staging guides treatment decisions
Doctors classify the cancer by its molecular profile, and that matters as much as staging does. Estrogen receptor-positive breast cancer responds to hormones and is the most common subtype. HER2-positive breast cancer overproduces a growth protein and responds to targeted therapies.
Triple-negative breast cancer lacks all three common receptors, estrogen receptor (ER), progesterone receptor, and HER2 receptor, making it harder to treat with targeted drugs. Risk stratification based on subtype helps shape the treatment plan. Two tumors that look identical on imaging can behave completely differently based on molecular type.
Genetic testing for breast cancer and biomarker analysis aren't optional extras. They're part of every modern breast cancer diagnosis. Women with a BRCA mutation or a strong family history of breast cancer risk should discuss genetic mutation screening with a breast oncologist. Molecular profiling changed how breast cancer gets treated more than almost anything else in the last twenty years. Most oncologists agree that skipping molecular testing.
Early diagnosis of breast cancer significantly improves treatment options and outcomes. Starting mammograms between the ages of 40 and 45 for average-risk women is what most guidelines recommend. Family history or a BRCA mutation? Screening should start earlier, sometimes as young as 25, with breast MRIs. Breast cancer diagnosis in younger women is less common but not rare, and delayed screening in high-risk groups can lead to later-stage detection.
Can breast cancer be detected early? It can. First, regular mammograms catch calcifications and small masses before they're palpable. Second, breast MRI fills the gap for high-risk women with dense tissue. Third, self-awareness about changes helps women seek care sooner.
The biggest barrier isn't technology. It's women skipping screening altogether. Symptoms leading to breast cancer diagnosis, like a new lump, skin dimpling, or nipple discharge, should prompt an immediate evaluation. Can breast cancer exist without symptoms? Absolutely, which is why mammography matters even when everything feels normal.
Breast oncologists at HCG Cancer Hospital handle breast cancer diagnosis from screening through molecular profiling. First, imaging tests such as a mammogram, ultrasound, or breast MRI help identify suspicious areas. Second, a core needle biopsy and histopathological examination confirm or rule out cancer. Third, molecular testing is used to classify the cancer subtype and guide targeted treatment planning.
Testing alone is not the only part of care at HCG Cancer Hospital. Once diagnosis and staging are complete, a multidisciplinary team, including surgeons, medical oncologists, and radiation specialists, builds a treatment plan tailored to the patient's cancer type and stage.
Genetic counseling is available for women with family history concerns, and support services help patients through each phase. Molecular profiling has significantly changed breast cancer treatment.
Book a breast cancer screening consultation at your nearest HCG Cancer Hospital center.
Disclaimer: This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare provider for any questions regarding a medical condition.
Dr. Saket Mittal
Consultant - Surgical Oncology
Appointment Link: Book an Appointment with Dr. Saket Mittal
Feel free to reach out to us.
